최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Pediatric infection and vaccine: PIV, v.22 no.3, 2015년, pp.164 - 171
박지원 (전주 예수병원 소아청소년과) , 정은초 (전주 예수병원 소아청소년과) , 박기철 (전주 예수병원 소아청소년과) , 장영택 (전주 예수병원 소아청소년과) , 박신애 (전주 예수병원 소아청소년과)
Purpose: To investigate the long-term prognosis of patients with Kawasaki disease in Korea, and discuss the need for long-term follow-up. Methods: The subjects were 48 patients among 354 who had been hospitalized due to Kawasaki disease, and who consented to echocardiography and exercise challenge t...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
가와사키병은 무엇인가? | 가와사키병(Kawasaki disease, KD)은 고열과 점막피부 질환을 보이는 원인불명의 전신성 혈관염으로 소아 연령에서 후천성 심질환의 가장 흔한 원인이다1). 치료하지 않으면 15-25%에서 관상 동맥류나 관상동맥 확장이 동반되며 이는 심근경색증, 허혈성 심질환 또는 급사의 원인이 되기도 한다2). | |
가와사키병은 언제 최초 보고되었으며 우리나라에서는 언제 보고되었는가? | 가와사키병은 1967년 일본에서 최초로 보고된 이후18) 세계적으로 발병이 확인되고 있으며 우리나라에서도 1973 년에 최초 보고가 있은 이후로19) 연 평균 발병률이 계속 증가하는 추세를 보이고 있다12). 2011년 기준으로 국내 5세 이하 소아 10만 명당 발병률이 134. | |
가와사키병을 치료하지 않으면 어떻게 되는가? | 가와사키병(Kawasaki disease, KD)은 고열과 점막피부 질환을 보이는 원인불명의 전신성 혈관염으로 소아 연령에서 후천성 심질환의 가장 흔한 원인이다1). 치료하지 않으면 15-25%에서 관상 동맥류나 관상동맥 확장이 동반되며 이는 심근경색증, 허혈성 심질환 또는 급사의 원인이 되기도 한다2). |
Taubert KA, Rowley AH, Shulman ST. Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J 1994;13:704-8.
Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al. Diagnosis and theraphy of Kawasaki disease in children. Circulation 1993;87:1776-80.
Melish ME. Kawasaki syndrome. Pediatr Rev 1996;17:153-62.
JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version. Circ J 2014;78:2521-62.
Suzuki A, Yamagishi M, Kimura K, Sugiyma H, Arakaki Y, Kamiya T, et al. Functional behavior and morphology of the coronary artery wall in patients with Kawasaki disease assessed by intravascular ultrasound. J Am Coll Cardiol 1996; 27:291-6.
Iemura M, Ishii M, Sugimura T, Akagi T, Kato H. Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart 2000;83:307-11.
Furuyama H, Odagawa Y, Katoh C, Iwado Y, Ito Y, Noriyasu K, et al. Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J Pediatr 2003;142:149-54.
Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996;94: 1379-85.
Nakamura Y, Aso E, Yashiro M, Tsuboi S, Kojo T, Aoyama Y, et al. Mortality among Japanese with a history of Kawasaki disease: results at the end of 2009. J Epidemiol 2013;23:429-34.
Suda K, Iemura M, Nishiono H, Teramachi Y, Koteda Y, Kishimoto S, et al. Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: a single-institution experience. Circulation 2011;123:1836-42.
Selamet Tierney ES, Gal D, Gauvreau K, Baker AL, Trevey S, O'Neill SR, et al. Vascular health in Kawasaki disease. J Am Coll Cardiol 2013;62:1114-21.
Kim GB, Han JW, Park YW, Song MS, Hong YM, Cha SH, et al. Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011. Pediatr Infect Dis J 2014;33:24-7.
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Pediatrics 2004;114:1708-33.
Kamiya T, Kawasaki T, Okuni M, Kato H, Baba K, Nakano H. Report of subcommittee on standardization of diagnostic criteria and report of coronary artery lesions in Kawasaki disease. Research committee on Kawasaki disease of the Ministry of Health and Welfare. 1984. pp. 1-10.
de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 1998;133: 254-8.
Armstrong WF, Pellikka PA, Ryan T, Crouse L, Zoghbi WA. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 1998;11:97-104.
Dajani AS, Taubert KA, Takahashi M, Bierman FZ, Freed MD, Ferrieri P, et al. Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki disease, Council on Cardiovascular Disease in the young, American Heart Association. Circulation 1994;89:916-22.
Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967;16:178-222.
Park JS, Seo CJ, Cho SH, Lee DB. Clinical observation of mucocutaneous lymph node syndrome: 5 cases. J Korean Pediatr Soc 1973;16:61-7.
Rhim JW, Youn YS, Han JW, Lee SJ, Oh JH, Lee KY. Changes in Kawasaki disease during 2 decades at a single institution in Daejeon, Korea. Pediatr Infect Dis J 2014;33:372-5.
Kim JJ, Hong YM, Yun SW, Han MK, Lee KY, Song MS, et al. Assessment of risk factors for Korean children with Kawasaki disease. Pediatr Cardiol 2012;33:513-20.
Kim T, Choi W, Woo CW, Choi B, Lee J, Lee K, et al. Predictive risk factors for coronary artery abnormalities in Kawasaki disease. Eur J Pediatr 2007;166:421-5.
Kim JW, Goo HW. Coronary artery abnormalities in Kawasaki disease: comparison between CT and MR coronary angiography. Acta Radiol 2013;54:156-63.
Ha KS, Jang G, Lee J, Lee K, Hong Y, Son C, et al. Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis. Eur J Pediatr 2013;172:343-9.
Joo HJ, Song MS, Kim CH. Follow-up method in patients with Kawasaki disease who had no coronary artery abnormalities in the convalescent period. Korean J Pediatr 2005; 48:165-73.
Paridon SM, Galioto FM, Vincent JA, Tomassoni TL, Sullivan NM, Bricker JT. Exercise capacity and incidence of myocardial perfusion defects after Kawasaki disease in children and adolescents. J Am Coll Cardiol 1995;25:1420-4.
Gravel H, Dahdah N, Fournier A, Mathieu ME, Curnier D. Ventricular repolarisation during exercise challenge occurring late after Kawasaki disease. Pediatr Cardiol 2012;33:728-34.
Hohls A. Cardiovascular follow-up 10-15 years post Kawasaki disease. Heart Lung Circ 2012;21:S143-S316.
Dunning DW, Hussey ME, Riggs T, Bestervelt R, Goerke C. Long-term follow-up with stress echocardiograms of patients with Kawasaki' disease. Cardiology 2002;97:43-8.
Rhodes J, Hijazi ZM, Marx GR, Fulton DR. Aerobic exercise function of patients with persistent coronary artery aneurysms secondary to Kawasaki disease. Pediatr Cardiol 1996; 17:226-30.
Zanon G1, Zucchetta P, Varnier M, Vittadello F, Milanesi O, Zulian F. Do Kawasaki disease patients without coronary artery abnormalities need a long-term follow-up? A myocardial single-photon emission computed tomography pilot study. J Paediatr Child Health 2009;45:419-24.
Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M, Kawasaki T. Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol 1996;28:253-7.
Satoda M, Tatsukawa H, Katoh S. Images in cardiovascular medicine. Sudden death due to rupture of coronary aneurysm in a 26-year-old man. Circulation 1998;97:705-6.
Tsuda E, Kamiya T, Ono Y, Kimura K, Echigo S. Dilated coronary arterial lesions in the late period after Kawasaki disease. Heart 2005;91:177-82.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.